XKDCT080 in GCC-positive Recurrent or Refractory Solid Tumors With Single Center, Single Arm, and Dose Escalation

Conditions

• Colon Cancer

Interventions

• DRUG: Chimeric antigen receptor T cell preparation targeting GCC

Sponsor

The Affiliated Hospital of Qingdao University